Biosensors & POCT– category –
-
UTMB Researchers Secure USDA Funding for AI-Enabled Nanobody Biosensor for Rapid Screwworm Detection, Achieving 15-Minute Field Results
The University of Texas Medical Branch USA Overview Researchers at the University of Texas Medical Branch (UTMB) have received USDA funding to develop an AI-enabled rapid detection system for screwworm, safeguarding Texas livestock and w... -
ASCO Breakthrough 2026 Unveils Over 300 Abstracts Highlighting Advances in Liquid Biopsy, Metabolic Risks, and Tailored Cancer Therapies for Asian Populations
American Society of Clinical Oncology (ASCO) / The ASCO Post USA Overview The American Society of Clinical Oncology (ASCO) has publicly released over 300 abstracts for its 2026 Breakthrough meeting in Singapore and online. The conference... -
Nanotechnology-Mediated Precision mRNA Delivery Revolutionizes Vaccines and Gene Therapies by Minimizing Off-Target Effects and Maximizing Efficiency
Nature Materials International Overview A Nature Materials review highlights advanced strategies for precision mRNA delivery to cells and tissues, aiming to minimize off-targeting and maximize efficiency. This technology is critical for ... -
Coherent 2D–3D van der Waals Perovskite Heterostructures Achieved with Atomically Sharp Interfaces and Gate-Tunable Rectification for Advanced Sensors
Nature Nanotechnology International Overview Research in Nature Nanotechnology details the successful growth of coherent 2D–3D van der Waals perovskite heterostructures via cross-dimensional epitaxy, yielding atomically sharp interfaces ... -
AI-Guided Microrobots Achieve Spatiotemporally Controlled Intracavitary Drug Release, Dramatically Enhancing Bladder Tumor Therapy in Murine Models
Nature Nanotechnology International Overview A breakthrough in Nature Nanotechnology introduces a deep learning-guided image-feedback system enabling non-invasive, real-time navigation and spatiotemporally controlled drug release from ma... -
Biosensors & POCT Weekly Report May 20, 2026
▼ ▼ ▼ If you found the infographic compelling and want to read the full Weekly Report, click below to download the Strategy Report. ▼ ▼ ▼ 📄 Biosensors & POCT Weekly Report — June 20, 2026 Biosensors_WeeklyReport_EN_20260620.pdfDownload ... -
Health Outcomes Data from Wearables Pivotal for Medicare Coverage Expansion
Forbes USA Overview Health outcomes data derived from wearable devices are proving crucial for expanding Medicare coverage in the United States. Researchers are actively studying the clinical and cost-effectiveness of various wearable te... -
SEMI Smart MedTech Initiative Identifies Key Obstacles and Opportunities for Scaling Wearable Biosensors into Clinical Use
SEMI USA Overview The SEMI Smart MedTech Initiative has published a paper detailing the challenges and opportunities in scaling wearable biosensors from wellness tracking to clinical applications. Despite advancements in semiconductor te... -
Wearable Sensors Underutilized in Clinical Research, Holding Key to Efficiency and Cost Reduction
Clinical Trials Arena UK Overview Despite their potential, wearable sensors remain largely underutilized in pharmaceutical clinical trials, according to Dudley Tabakin, CEO of VivoSense, at the OCT UK & Ireland 2026 conference. He em... -
FDA Reclassifies SARS-CoV-2 POCT Devices to Class II, Easing Regulatory Burden for Rapid Diagnostics
GovInfo (Federal Register) USA Overview The U.S. FDA has issued a final rule, effective June 11, 2026, reclassifying simple point-of-care (POCT) devices for direct detection of SARS-CoV-2 viral targets to Class II (special controls). Thi...
